Management guidelines for venous thrombosis in the lower limbs according to the European Society of Vascular Surgery 2021.
Deep vein thrombosis (DVT) is caused by a fibrin thrombus which reduces the blood supply to the surrounding tissues. Within the complications reported in the literature we find pulmonary embolic events (PE), which, once generated, develop great repercussions on the survival of those who suffer from...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2022
- Institución:
- Pontificia Universidad Javeriana Cali
- Repositorio:
- Vitela
- Idioma:
- spa
- OAI Identifier:
- oai:vitela.javerianacali.edu.co:11522/483
- Acceso en línea:
- https://revistas.javerianacali.edu.co/index.php/salutemscientiaspiritus/article/view/682
https://vitela.javerianacali.edu.co/handle/11522/483
- Palabra clave:
- Trombosis venosa profunda
Tromboembolismo venoso
Embolismo pulmonar
Ecografía por compresión de dos o tres puntos
Ecografía de toda la pierna
Síndrome antifosfolípidico
Abuso de sustancias
Heparina no fraccionada
Antagonista de la vitamina k
Heparina bajo peso molecular
Anticoagulantes orales directos
Deep vein thrombosis
Venous thromboembolism
Pulmonary embolism
Two or three point compression ultrasound
Whole leg ultrasound
Antiphospholipid syndrome
Unfractionated heparin
Vitamin K antagonist
Low molecular weight heparin
Direct oral anticoagulants
- Rights
- License
- Derechos de autor 2023 Salutem Scientia Spiritus
Summary: | Deep vein thrombosis (DVT) is caused by a fibrin thrombus which reduces the blood supply to the surrounding tissues. Within the complications reported in the literature we find pulmonary embolic events (PE), which, once generated, develop great repercussions on the survival of those who suffer from them. The diagnosis is made in a multidisciplinary manner, using measures such as the Wells score, D-dimer measurement, computed venography, among others. The European Society of Vascular Surgery in its 2021 clinical practice guideline, mentions the appropriate way to make the diagnosis, taking into account the risk factors, the classification according to the triggering factor and the currently available images. Likewise, it indicates the treatment that should be offered based on the location of the thrombus and what pharmacological and non-pharmacological measures can be chosen in different clinical scenarios. The following review highlights the key and most relevant aspects to take into account for the management of patients with this entity. |
---|